Drawing for GYNI

USPTO serial 97825966

GYNI

Reviewed by CopyMark Law Group

Reg. 7691955Status 700Registered
Filing date
Status date
Registration date
Feb 18, 2025
Examiner
WITKOWSKI, RYAN MICHAEL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GYNI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Holly M. Ford Lewis

Holly M. Ford Lewis Panitch Schwarze Belisario & Nadel LLP2005 Market Street, Suite 3325One Commerce SquarePhiladelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents and assays for testing bodily fluids for microorganisms; medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions; medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions, namely, vaginitis, STDs, and other feminine medical disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for microorganisms; diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions; and diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions, namely, vaginitis, STDs, and other feminine medical disordersACTIVE
009Downloadable mobile applications featuring medical information for use by female patients and healthcare service providers for obtaining gynecological informationACTIVE
010Medical devices and instruments for obtaining female patient specimens; medical devices and instruments for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; disposable medical devices and instruments for obtaining female patient specimens; disposable medical devices and instruments for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens; medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; disposable medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens; disposable medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditionsACTIVE
044Consultation services in the field of medical care relating to the detection, diagnosis, health care management, and treatment of gynecological conditionsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 8, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 8, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 16, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 16, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 16, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 16, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 16, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 16, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 2, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 2, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 2, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 2, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 2, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 2, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2024OTHECASE RETURNED TO EXAMINATION
Nov 26, 2024IUCNNOTICE OF ALLOWANCE CANCELLED
Nov 26, 2024PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Nov 19, 2024ERTITEAS RESPONSE TO PETITION INQUIRY LETTER
Nov 18, 2024PILMPETITION INQUIRY LETTER ISSUED
Nov 13, 2024APETASSIGNED TO PETITION STAFF
Oct 18, 2024TPADTEAS PETITION TO AMEND BASIS RECEIVED
Jul 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 7, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 28, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 26, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2023DOCKASSIGNED TO EXAMINER
Jul 21, 2023AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 21, 2023ALIEASSIGNED TO LIE
Mar 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2023PARITEAS VOLUNTARY AMENDMENT RECEIVED
Mar 10, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance